Senior insider sale
Chief Scientific Officer at INDIVIOR PHARMACEUTICALS, INC. — senior position signals high conviction
$1.47M
37.17K shares
What this filing means
HEIDBREDER CHRISTIAN plans to sell 37.17K shares of INDIVIOR PHARMACEUTICALS, INC. valued at approximately $1.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/10/2026ACC: 0001959173-26-005188
Officer· Chief Scientific Officer
Since Mar 2026
37.17K
Shares to sell
$1.47M
Approx. market value
18.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/3/2026
18.59KTotal acquired18.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Restricted Stock Vesting Compensation | 18.59K | — |
| Total | 18.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
18.59K
Market value
$707.4K
6/11/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
18.59K
Market value
$764.6K
7/10/2026
Total
Units
37.17K
Value
$1.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/11/2026 | 18.59K | $707.4K | — | Completed |
| Planned — Approximate Date | ||||
7/10/2026 | 18.59K | $764.6K | NASDAQ | Planned |
| Total | 37.17K | $1.47M | ||